Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Sargramostim + VBI-1901 |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Sargramostim | Leukine | GM-CSF|Prokine | ||
| VBI-1901 | VBI1901|VBI 1901 | VBI-1901 is a vaccine comprising enveloped virus-like particles that contain GM-CSF linked to the cytomegalovirus antigens, glycoprotein B (gB) and phosphoprotein 65 (pp65), thereby potentially stimulating an immune attack against gB and pp65-expressing cancer cells (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|